Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease
- 1 March 1997
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (5) , 698-702
- https://doi.org/10.1038/bjc.1997.124
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic indexCancer, 1991
- Objective measurement of therapeutic response in breast cancer using tumour markersBritish Journal of Cancer, 1991
- Cancer Mortality in Italy: An Overview of Age-Specific and Age-Standardised Trends from 1955 TO 1984Tumori Journal, 1990
- Circulating tumor markers in breast cancer (review).1990
- Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic diseaseCancer, 1989
- Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancerThe International Journal of Biological Markers, 1989
- COMPARISON OF CA15-3 AND CARCINOEMBRYONIC ANTIGEN IN MONITORING THE CLINICAL COURSE OF PATIENTS WITH METASTATIC BREAST-CANCER1988
- Clinical course of breast cancer patients with liver metastases.Journal of Clinical Oncology, 1987
- Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.Journal of Clinical Oncology, 1987
- PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER TREATED WITH COMBINATION CHEMOTHERAPY1979